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Background: Needle access or drainage of pericardial effusion, especially when small, entails risk of bystander
tissue injury or operator uncertainty about proposed trajectories. Cardiovascular magnetic resonance (CMR) might
allow enhanced imaging guidance.
Methods and results: We used real-time CMR to guide subxiphoid pericardial access in naïve swine using
commercial 18G titanium puncture needles, which were exchanged for pericardial catheters. To test the value of
CMR needle pericardiocentesis, we also created intentional pericardial effusions of a range of volumes, via a
separate transvenous-transatrial catheter. We performed these procedures in 12 animals.
Pericardiocentesis was performed in 2:47 ± 1:43 minutes; pericardial access was performed in 1:40 ± 4:34 minutes.
The procedure was successful in all animals. Moderate and large effusions required only one needle pass. There
were no complications, including pleural, hepatic or myocardial transit.
Conclusions: CMR guided pericardiocentesis is attractive because the large field of view and soft tissue imaging
depict global anatomic context in arbitrary planes, and allow the operator to plan trajectories that limit inadvertent
bystander tissue injury. More important, CMR provides continuous visualization of the needle and target throughout
the procedure. Using even passive needle devices, CMR enabled rapid pericardial needle access and drainage. We
believe this experience supports clinical testing of real-time CMR guided needle access or drainage of the
pericardial space. We suspect this would be especially helpful in “difficult” pericardial access, for example, in
distorted thoracic anatomy or loculated effusion.
Keywords: Pericardiocentesis, Catheterization, Image guided intervention, Interventional magnetic resonance
imaging, Cardiovascular magnetic resonance, Pericardial diseaseBackground
Pericardiocentesis is a common catheter technique to
sample or drain fluid from the pericardial space [1]. Peri-
cardial access may be desirable even without effusion in
certain procedures such as epicardial ablation of rhythm
disorders [2], or atrial appendage exclusion [3]. Peri-
cardiocentesis is performed using a long subxiphoid or
transthoracic needle. Pericardiocentesis may be guided
(A) using surface landmarks (“blindly”), (B) using electro-* Correspondence: lederman@nih.gov
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reproduction in any medium, provided the orgrams to detect epicardial needle contact, (C) using echo-
cardiography, (D) using X-ray with- or without- contrast
injections, or (E) using a combination. Each has advan-
tages and limitations.
Typically, adjunctive imaging decreases procedural risk
for difficult-to-access pericardial fluid collections (smaller
volume, posterior location, loculated fluid, compartmen-
talized fluid collections, thick or calcified pericardium,
large body habitus, etc.). In practice, most clinical tech-
niques focus more on trajectory planning than on guid-
ing live needle advancement to achieve pericardial
access without bystander injury. Planar echocardiography
imaging rarely allows the operator to view needle,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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eously. Projection fluoroscopic imaging provides a large
field of view, but uncertainty about three-dimensional
position of soft tissue. Enhanced imaging guidance would
be desirable.
We [4] and others [5-9] use real-time cardiovascular
magnetic resonance (CMR) to guide clinical heart
catheterization by tissue and chamber visualization but
without X-ray radiation. We hypothesize CMR can also
guide pericardiocentesis. Real-time CMR depicts the
entire thoracic context for needle access, allowing the
operator to avoid critical structures including the liver,
lung, pleural space, and heart muscle. We evaluate the
safety and feasibility of real-time CMR guided needle
pericardiocentesis in animals with and without peri-
cardial effusions, using commercially available CMR-
compatible (“passive”) access needles.
Methods
Animal model
Animal procedures were approved by the institutional
animal care and use committee, and followed contempor-
ary National Institutes of Health guidelines. Twelve naïve
Yorkshire swine (Animal Biotech Industries, Danboro,
PA) were anesthetized with atropine, butorphanol, keta-
mine, and xylazine, and maintained on isoflurane with
mechanical ventilation. Percutaneous arterial and venous
access was obtained.
Four groups of three animals were tested, having either
no effusion, small (50 ml), moderate (100 ml), or large
(150 ml) effusions. Pericardial effusions of known volumes
were created by infusing normal saline using separate
transfemoral catheters that crossed the right atrial append-
age into the pericardial space [10]. Catheters were placed
under X-ray prior to CMR. After effusions were created,
hemodynamics were recorded, CMR was performed,
and drainage was attempted. The time interval between
creating and draining effusions was approximately five
minutes. Pericardial catheters were not placed in the
“no effusion animals” to avoid distorting normal peri-
cardial volume.
Magnetic resonance imaging
Experiments were conducted in a combined interven-
tional CMR and X-ray fluoroscopy suite (1.5T Espree.
Axiom Artis; Siemens, Erlangen, Germany) detailed else-
where [4]. Hemodynamics were recorded continuously.
CMR headsets afford acoustic sound suppression and
“open-microphone” communications among staff and on
a second channel in case of an awake patient (IMROC,
Opto-acoustics, Moshav Mazor, Israel). Interventional
procedures were guided by real-time balanced steady-
state free precession (bSSFP) and the following para-
meters: repetition time (TR) / echo time (TE), 2.88/1.44 ms; flip angle, 40°; bandwidth, 1000 Hz/pixel; field
of view (FOV), 350 mm; matrix 144 × 192 pixels; and
slice thickness, 6 mm, GRAPPA rate 1–2, with a temporal
resolution up to 150 ms (7 frames/s). We used a prototype
commercial real-time CMR user interface (Interactive
Front End, Siemens Corporate Research, Princeton) for
trajectory planning in multiple planes and for imaging
guidance of the interventional procedure.
Pericardial effusion size was measured using bSSFP
CMR with the following typical ECG triggered, breath-
held parameters: TR/TE, 3/1.3 ms and partial-echo
readout; flip angle, 65°; bandwidth, 1028 Hz/pixel; fat-
saturation prepulses, FOV, 344 mm; matrix, 256 × 256
pixels; slice thickness, 10 mm; 10 slices (axial, coronal,
sagittal).Real-time CMR guided pericardiocentesis
Subxiphoid needle entry and trajectory were planned on
real-time images, typically oblique coronal and sagittal
views (Figure 1). We used CMR compatible needles
marketed in the US (CMR Puncture Needle, 18G ×
15 cm, Philips Invivo, Schwerin, Germany).
The needle was advanced using real-time CMR guid-
ance to maintain a planned trajectory. In animals having
an effusion, pericardial entry was confirmed using CMR.
In these animals, pericardial entry was corroborated by
tactile feedback, ectopic heart beats, and fluid aspiration.
In animals having no effusion (“dry tap”), the pericar-
dium was entered and corroborative test injection of saline
(10–20 ml) through the needle was performed using real-
time CMR. Pericardial access was confirmed by instilling
saline after a pericardial “pigtail” catheter was introduced
over a nitinol guidewire. Animals were observed for
60 minutes after the procedure to detect complications.Data analysis
We recorded success or failure, number of needle at-
tempts, and complications. We recorded the time required
to perform certain procedure elements, including CMR
time required to plan the trajectory, and time required to
access the pericardial space after the needle crossed the
skin. Hemodynamics were reported before and after inter-
vention. Effusions were measured by maximal dimension
in three planes (axial, coronal, and sagittal).
Results are expressed as mean ± standard deviation,
and where appropriate, 95% confidence interval or
range. Time to perform procedure steps are expressed as
median and range. Continuous parameters were tested
using analysis of variance and Tukey’s correction for
multiple comparisons. The numbers of discrete needle
attempts for different sized effusions were compared
using a Kruskal-Wallis test with Dunn's correction for
multiple comparisons. Data were analyzed using Microsoft
Figure 1 Trajectory planning: Real time CMR pericardiocentesis.
Real-time CMR system user interface (Interactive Front End, Siemens
Corporate Research, Princeton) is used for trajectory planning. The
prescribed slice planes intersect along the projected needle path.
The operator finger (white arrow) depresses the subxiphoid skin
surface to mark the proposed needle entry site. Panel A (coronal)
and B (sagittal) is an animal with a large (150 ml) effusion. Panel
C (coronal) and D (sagittal) is an animal with no effusion. Posterior
trajectory is chosen. The blue dotted line indicates an axial imaging
plane prescription that is not shown.
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sidered significant.Results
Twelve animals (41.1 ± 3.5 kg) were studied
No pericardial separation was evident in the animals
without baseline effusion. Small (50 mL) effusions had
maximal two-dimensional pericardial separation less
than 10 mm. Moderate (100 mL) effusions measured
between 10-20 mm, and large (150 mL) effusions were









Small (50 ml) 48.4 ± 3.0 3.4 ± 1.2 9.5
Moderate
(100 ml)
98.3 ± 3.7 6.1 ± 1.1 16.7
Large (150 ml) 146.3 ± 4.8 4.8 ± 0.7 20.8
Volumes are expressed in milliliters (ml). The units for pressure are millimeter of Me
per group.For procedure guidance, we used non-standard cardiac
oblique planes such as four-chamber and three-chamber
long axis views, tailored for the maximum evident effu-
sion. Because CMR depicts a broad anatomic context,
we found it equally easy to access anterior and posterior
pericardial spaces (Figures 1 & 2).
Real-time CMR pericardial needle entry was successful
in all. CMR guided pericardiocentesis was successful in
all animals evident by fluid evacuation or purposeful
accumulation (no effusion group).
Trajectory planning time took approximately one mi-
nute or less. Moderate and large effusions all required
only one needle pass (p < 0.05 compared with no effu-
sion). Small effusions required 2.7 ± 1.2 passes (p = NS
compared with no effusion). Access without effusions
required 3.3 ± 1.2 passes. Larger effusions required nu-
merically but not statistically shorter access and proced-
ure times (Table 2).
Acute effusions decreased blood pressure. Heart rates
did not increase. Drainage restored hemodynamics to
near baseline (Figure 3). Cardiac tamponade physiology
(systemic systolic blood pressure decrease of 15%) [11]
was elicited with even small (50 mL) effusions (13.1% ±
10.6%, p < 0.05; 95% confidence interval of difference =
2.2 mm Hg to 18.1 mm Hg). Bigger (100 or 150 mL)
effusions produced progressively more dramatic com-
promise (moderate, 30.5% ± 15.1%, p < 0.05; 95% confi-
dence interval of difference = 13.9 to 30.9; and large,
46.2% ± 14.1%, p < 0.05; 95% confidence interval of dif-
ference = 23.5 to 40.9 respectively).
None of the following known complications of peri-
cardiocentesis were observed: sustained dysrhythmia,
coronary or thoracic wall vessel puncture, ventricle lacer-
ation, hemothorax, pneumothorax, pneumopericardium,
hepatic injury, death [12].
Discussion
We found that real-time CMR guided pericardial access
and pericardiocentesis was successful in every attempt.
This included animals with small and no pericardial
effusions. Procedures were quick with no complications.
As expected, larger effusions were easier and faster to
access. This was accomplished using off-the-shelf com-






± 2.4 9.4 ± 2.1 8.6 ± 0.7
± 3.5 16.6 ± 3.3 12.4 ± 1.6
± 3.8 22.1 ± 3.6 15.9 ± 2.2
rcury (mmHg). Maximum dimensions are represented in millimeters. n = 12
Figure 2 Real time CMR guided pericardiocentesis using a
“passive” needle. Real time CMR guides pericardiocentesis
performed with commercially available, off-the-shelf needle
(white arrow). Panels A and B show typical long-axis imaging planes
selected by the operators. This animal has a small (50 ml) effusion.
Note the “saturation band” of reduced T1 recovery (and reduced
signal) where the two imaging planes intersect.
Figure 3 Hemodynamics. Systemic peak systolic blood pressure
(SBP; mmHg) and heart rate (HR; bpm= beats per minute) are charted
for small, moderate (mod), and large pericardial effusions at baseline,
after the effusion is created, and after drainage. All effusions caused
hemodynamic changes that returned to baseline after drainage.
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guidance, such as when death is otherwise imminent.
Imaging guidance may reduce complications (procedure
failure; coronary, myocardial or hepatic laceration; sus-
tained arrhythmia, etc.). X-ray fluoroscopy projection has
limited ability to distinguish pericardial from myocardial
boundaries, and is poor at depicting three-dimensional
position. Ultrasound may interfere with operator access,
may be limited by acoustic windows, and has a limited
field of view that may not depict the global anatomic
context. By contrast, CMR combines superior soft tissue
visualization, a larger field of view, multi-planar capability,
and continuous visualization of the needle and target
throughout the procedure.
In this pre-clinical experience, we found real-time
CMR guidance useful. CMR visualization of device, tra-
jectory, and target enhanced operator subjective confi-
dence in procedure steps. Objectively, pericardial access










































Values are median and range. * = p < 0.05 compared with no effusion. n = 3
per group.irrespective of pericardial fluid volume, even in this
early-stage experiment. The temporal resolution was
adequate to guide the procedure in these animals with
clinically-relevant tachycardia. Our success in animals
having no effusion suggests potential value in other pro-
cedures requiring pericardial or epicardial access. The
large field of view afforded by CMR may facilitate
alternative, unconventional (mid-clavicular, mid-axillary)
approaches to drain non-circumferential, difficult-to-ac-
cess pericardial fluid [13], or very small pericardial effu-
sions [14]. We only evaluated subxiphoid access because
of the subxiphoid orientation of the porcine cardiac
apex; in other work we accessed the porcine heart and
pericardial space via intercostal approaches [15,16].
In this experiment, we showed good success using
“passive” commercial CMR needles that are visualized
based on intrinsic materials properties. In other work,Figure 4 Comparison of “passive” versus “active” visualization
of needles during CMR guided pericardial access. The “passive”
titanium needle (panel A, black artifact indicated with white arrows)
is compared with an “active” antenna needle (panel B, green
colorized signal indicated with white arrow). The active needle is
more conspicuous. This demonstration uses a lateral access
approach and no pericardial effusion.
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“active” antenna-needle (Figure 4) [17]. Both may enable
more sophisticated non-surgical treatments for structural
heart disease, including direct transthoracic implantation
of large appliances into the heart [16].
Several limitations are noteworthy. Few clinical CMR
systems currently are configured for interventional pro-
cedures including in-room display, interactive control,
acoustic sound compression, open-microphone commu-
nications systems, and high-fidelity hemodynamic moni-
toring, although these represent a small incremental
increase in cost. Even large-bore CMR systems constrain
access to the chest or subxiphoid space, although we
have found this readily surmountable even for sterile
procedures in our preclinical experience and in human
volunteers [data not shown]. Although we used clinical
CMR needles, there are currently no commercially avail-
able safe and conspicuous CMR guidewires to be used in
tandem with our access needle. Iron-doped polymer pas-
sive devices have shown mixed performance in early de-
velopment [7]. We chose to use interleaved multiplanar
CMR which creates a “saturation” artifact along their
line of intersection that usually coincides with the de-
sired needle trajectory (see Figure 2); this further limits
the visibility of passive needles except when single-plane
imaging is selected interactively. Passive needles are dif-
ficult to visualize outside the body before the operator
commits to a needle trajectory. We believe active devices
may enhance visibility and safety, and therefore we are
developing clinical-grade active needles [17] and guide-
wires [18]. Finally, interventional CMR remains investi-
gational and is not yet widely deployed.
Conclusion
In conclusion, we found real-time CMR allowed successful
and rapid pericardial entry and pericardiocentesis in swine
irrespective of pericardial volume, using off-the-shelf nee-
dle devices. Clinical testing is underway.
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